# MEDITA Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medita-co

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: https://herbio.co.jp
- Total disclosed funding: $1.2M
- Latest round: Series B (Jan 20, 2021)
- Investors on record: 4

## About

MEDITA Co., Ltd. is a Tokyo-based company focused on developing and distributing innovative herbal-based health products, catering to wellness practitioners and consumers with a commitment to quality and efficacy.Founded in 2017 in Tokyo, Japan, MEDITA Co., Ltd. specializes in herbal-based health products and dietary supplements. The company has secured a total of 2 deals, with its most recent funding round occurring on January 20, 2021. During this Series B round, MEDITA raised JPY 122 million from investors Beyond Next Ventures and Velocity LLP, bringing the total amount raised to JPY 122 million and the current company valuation to JPY 700.366 million.Herbio Co., Ltd. specializes in the development and distribution of innovative herbal-based health products and dietary supplements. Their core offerings include a range of herbal extracts and formulations designed to enhance wellness and address various health concerns. These products are engineered to support immune function, promote digestive health, and improve overall vitality, thereby catering to a diverse clientele seeking natural health solutions. The company serves a wide range of end users, including health-conscious consumers, wellness practitioners, and retailers in markets such as North America, Europe, and parts of Asia. Each product is meticulously crafted using high-quality ingredients, emphasizing the company's commitment to efficacy and safety in natural health.Herbio operates primarily through a B2B model, engaging in direct partnerships with retailers and wellness centers to distribute its products. The company’s revenue is generated from bulk orders of its flagship herbal formulations, which are tailored to meet the specific needs of businesses in the health and wellness sector. The pricing structure for these products reflects their premium quality, with tailored packages available for various business sizes and needs. Transactions are generally structured around long-term partnerships, with clients often placing recurring orders based on sales performance and customer demand. This approach allows Herbio to maintain a stable revenue stream while ensuring that their partners receive consistent product supply and support.MEDITA Co., Ltd. aims to leverage the recent Series B funding of JPY 122 million raised on January 20, 2021, to further enhance its product line and market reach. The company is currently developing new herbal formulations with targeted release dates aimed at expanding its offerings in the health and wellness sector. Plans for market expansion are focused on increasing its presence within North America and Europe by the end of 2023, capitalizing on growing consumer demand for natural health solutions.

## Funding rounds

- Series B, Jan 20, 2021, $1.2M — Beyond Next Ventures, Velocity LLP
- Seed, Aug 31, 2018 — iSGS Investment Works, ABBALab

## Investors

- iSGS Investment Works (https://capitalatlas.ai/funds/isgs-investment-works) — Seed
- ABBALab (https://capitalatlas.ai/funds/abbalab) — Seed
- Beyond Next Ventures (https://capitalatlas.ai/funds/beyond-next-ventures) — Series B
- Velocity LLP — Series B